tiprankstipranks
Trending News
More News >
Cigna Corp (CI)
NYSE:CI
US Market

Cigna (CI) Stock Forecast & Price Target

Compare
3,319 Followers
See the Price Targets and Ratings of:

CI Analyst Ratings

Strong Buy
20Ratings
Strong Buy
16 Buy
4 Hold
0 Sell
Based on 20 analysts giving stock ratings to
Cigna
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CI Stock 12 Month Forecast

Average Price Target

$380.79
▲(20.89%Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is $380.79 with a high forecast of $407.00 and a low forecast of $341.00. The average price target represents a 20.89% change from the last price of $314.99.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"273":"$273","408":"$408","306.75":"$306.8","340.5":"$340.5","374.25":"$374.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":407,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$407.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":380.79,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$380.79</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":341,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$341.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[273,306.75,340.5,374.25,408],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,314.99,322.0676923076923,329.1453846153846,336.2230769230769,343.3007692307692,350.3784615384615,357.4561538461538,364.5338461538462,371.6115384615385,378.6892307692308,385.7669230769231,392.8446153846154,399.9223076923077,{"y":407,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,314.99,320.0515384615385,325.11307692307696,330.1746153846154,335.23615384615385,340.29769230769233,345.3592307692308,350.4207692307692,355.4823076923077,360.5438461538462,365.60538461538465,370.66692307692307,375.72846153846154,{"y":380.79,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,314.99,316.9907692307692,318.9915384615385,320.9923076923077,322.99307692307696,324.99384615384616,326.9946153846154,328.99538461538464,330.99615384615385,332.99692307692305,334.9976923076923,336.9984615384615,338.9992307692308,{"y":341,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":338.8,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":322.08,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":328.33,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":357.16,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":344.94,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":313.63,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":334.01,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":274.79,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":292.77,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":307.34,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":331,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":335.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":314.99,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$407.00Average Price Target$380.79Lowest Price Target$341.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CI
Ben HendrixRBC Capital
RBC Capital
$371
Buy
17.78%
Upside
Reiterated
06/02/25
RBC Capital Keeps Their Buy Rating on Cigna (CI)
Barclays
$382$385
Buy
22.23%
Upside
Assigned
06/02/25
Cigna price target raised to $385 from $382 at BarclaysCigna price target raised to $385 from $382 at Barclays
UBS
$390
Buy
23.81%
Upside
Reiterated
05/23/25
UBS reiterates Buy Rating on CIGNA (CI)UBS analyst AJ Rice reiterated a Buy rating and $390.00 price target on CIGNA (NYSE: CI).
Guggenheim Analyst forecast on CI
Jason CassorlaGuggenheim
Guggenheim
$388
Buy
23.18%
Upside
Reiterated
05/23/25
Guggenheim Sticks to Its Buy Rating for Cigna (CI)
Truist Financial Analyst forecast on CI
David S MacdonaldTruist Financial
Truist Financial
$385$405
Buy
28.58%
Upside
Reiterated
05/12/25
Cigna price target raised to $405 from $385 at TruistCigna price target raised to $405 from $385 at Truist
Wells Fargo Analyst forecast on CI
Stephen BaxterWells Fargo
Wells Fargo
$341
Hold
8.26%
Upside
Reiterated
05/12/25
Cigna's Stable Outlook Amid Positive Q1 Results and Manageable PBM Reforms
Bernstein Analyst forecast on CI
Lance WilkesBernstein
Bernstein
$323$373
Hold
18.42%
Upside
Reiterated
05/07/25
CIGNA (CI) PT Raised to $373 at Bernstein, Reflecting Modestly Lower Policy RiskBernstein SocGen Group analyst Lance Wilkes raised the price target on CIGNA (NYSE: CI) to $373.00 (from $323.00) while maintaining a Market Perform rating.
J.P. Morgan Analyst forecast on CI
Lisa GillJ.P. Morgan
J.P. Morgan
Buy
Reiterated
05/06/25
Analysts Are Bullish on Top Healthcare Stocks: Corbus Pharmaceuticals (CRBP), Cigna (CI)
CFRA
$304$392
Hold
24.45%
Upside
Downgraded
05/06/25
CFRA downgrades CIGNA (CI) to HoldCFRA analyst Paige Meyer downgraded CIGNA (NYSE: CI) from Buy to Hold with a price target of $392.00 (from $304.00).
Oppenheimer
$375
Buy
19.05%
Upside
Reiterated
05/05/25
Oppenheimer Remains a Buy on Cigna (CI)
Morgan Stanley Analyst forecast on CI
Erin WrightMorgan Stanley
Morgan Stanley
$379$390
Buy
23.81%
Upside
Reiterated
05/05/25
Cigna's Strategic Innovations and Financial Resilience Justify Buy Rating
Jefferies Analyst forecast on CI
David WindleyJefferies
Jefferies
$376$397
Buy
26.04%
Upside
Reiterated
05/05/25
CIGNA (CI) PT Raised to $397 at JefferiesJefferies analyst David Windley raised the price target on CIGNA (NYSE: CI) to $397.00 (from $376.00) while maintaining a Buy rating.
Raymond James Analyst forecast on CI
John RansomRaymond James
Raymond James
$360$385
Buy
22.23%
Upside
Reiterated
05/05/25
CIGNA (CI) PT Raised to $385 at Raymond JamesRaymond James analyst John Ransom raised the price target on CIGNA (NYSE: CI) to $385.00 (from $360.00) while maintaining a Strong Buy rating.
Leerink Partners Analyst forecast on CI
Whit MayoLeerink Partners
Leerink Partners
$325$365
Hold
15.88%
Upside
Reiterated
05/05/25
Cigna's Balanced Risk/Reward Scenario: Strong Earnings with Cautious Outlook
Piper Sandler Analyst forecast on CI
Jessica TassanPiper Sandler
Piper Sandler
$374
Buy
18.73%
Upside
Reiterated
05/05/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: OKYO Pharma Limited Sponsored ADR (NASDAQ: OKYO), Biogen (NASDAQ: BIIB) and Cigna (NYSE: CI)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on CI
Ben HendrixRBC Capital
RBC Capital
$371
Buy
17.78%
Upside
Reiterated
06/02/25
RBC Capital Keeps Their Buy Rating on Cigna (CI)
Barclays
$382$385
Buy
22.23%
Upside
Assigned
06/02/25
Cigna price target raised to $385 from $382 at BarclaysCigna price target raised to $385 from $382 at Barclays
UBS
$390
Buy
23.81%
Upside
Reiterated
05/23/25
UBS reiterates Buy Rating on CIGNA (CI)UBS analyst AJ Rice reiterated a Buy rating and $390.00 price target on CIGNA (NYSE: CI).
Guggenheim Analyst forecast on CI
Jason CassorlaGuggenheim
Guggenheim
$388
Buy
23.18%
Upside
Reiterated
05/23/25
Guggenheim Sticks to Its Buy Rating for Cigna (CI)
Truist Financial Analyst forecast on CI
David S MacdonaldTruist Financial
Truist Financial
$385$405
Buy
28.58%
Upside
Reiterated
05/12/25
Cigna price target raised to $405 from $385 at TruistCigna price target raised to $405 from $385 at Truist
Wells Fargo Analyst forecast on CI
Stephen BaxterWells Fargo
Wells Fargo
$341
Hold
8.26%
Upside
Reiterated
05/12/25
Cigna's Stable Outlook Amid Positive Q1 Results and Manageable PBM Reforms
Bernstein Analyst forecast on CI
Lance WilkesBernstein
Bernstein
$323$373
Hold
18.42%
Upside
Reiterated
05/07/25
CIGNA (CI) PT Raised to $373 at Bernstein, Reflecting Modestly Lower Policy RiskBernstein SocGen Group analyst Lance Wilkes raised the price target on CIGNA (NYSE: CI) to $373.00 (from $323.00) while maintaining a Market Perform rating.
J.P. Morgan Analyst forecast on CI
Lisa GillJ.P. Morgan
J.P. Morgan
Buy
Reiterated
05/06/25
Analysts Are Bullish on Top Healthcare Stocks: Corbus Pharmaceuticals (CRBP), Cigna (CI)
CFRA
$304$392
Hold
24.45%
Upside
Downgraded
05/06/25
CFRA downgrades CIGNA (CI) to HoldCFRA analyst Paige Meyer downgraded CIGNA (NYSE: CI) from Buy to Hold with a price target of $392.00 (from $304.00).
Oppenheimer
$375
Buy
19.05%
Upside
Reiterated
05/05/25
Oppenheimer Remains a Buy on Cigna (CI)
Morgan Stanley Analyst forecast on CI
Erin WrightMorgan Stanley
Morgan Stanley
$379$390
Buy
23.81%
Upside
Reiterated
05/05/25
Cigna's Strategic Innovations and Financial Resilience Justify Buy Rating
Jefferies Analyst forecast on CI
David WindleyJefferies
Jefferies
$376$397
Buy
26.04%
Upside
Reiterated
05/05/25
CIGNA (CI) PT Raised to $397 at JefferiesJefferies analyst David Windley raised the price target on CIGNA (NYSE: CI) to $397.00 (from $376.00) while maintaining a Buy rating.
Raymond James Analyst forecast on CI
John RansomRaymond James
Raymond James
$360$385
Buy
22.23%
Upside
Reiterated
05/05/25
CIGNA (CI) PT Raised to $385 at Raymond JamesRaymond James analyst John Ransom raised the price target on CIGNA (NYSE: CI) to $385.00 (from $360.00) while maintaining a Strong Buy rating.
Leerink Partners Analyst forecast on CI
Whit MayoLeerink Partners
Leerink Partners
$325$365
Hold
15.88%
Upside
Reiterated
05/05/25
Cigna's Balanced Risk/Reward Scenario: Strong Earnings with Cautious Outlook
Piper Sandler Analyst forecast on CI
Jessica TassanPiper Sandler
Piper Sandler
$374
Buy
18.73%
Upside
Reiterated
05/05/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: OKYO Pharma Limited Sponsored ADR (NASDAQ: OKYO), Biogen (NASDAQ: BIIB) and Cigna (NYSE: CI)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cigna

1 Month
xxx
Success Rate
21/30 ratings generated profit
70%
Average Return
+3.07%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.00% of your transactions generating a profit, with an average return of +3.07% per trade.
3 Months
xxx
Success Rate
21/30 ratings generated profit
70%
Average Return
+6.20%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +6.20% per trade.
1 Year
Scott FidelStephens
Success Rate
21/27 ratings generated profit
78%
Average Return
+19.14%
reiterated a buy rating 4 months ago
Copying Scott Fidel's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +19.14% per trade.
2 Years
xxx
Success Rate
17/18 ratings generated profit
94%
Average Return
+26.55%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 94.44% of your transactions generating a profit, with an average return of +26.55% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CI Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
0
0
0
0
Buy
20
21
12
22
22
Hold
4
5
3
5
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
26
15
27
26
In the current month, CI has received 22 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. CI average Analyst price target in the past 3 months is 380.79.
Each month's total comprises the sum of three months' worth of ratings.

CI Financial Forecast

CI Earnings Forecast

Next quarter’s earnings estimate for CI is $7.13 with a range of $6.67 to $7.39. The previous quarter’s EPS was $6.74. CI beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year CI has Outperformed its overall industry.
Next quarter’s earnings estimate for CI is $7.13 with a range of $6.67 to $7.39. The previous quarter’s EPS was $6.74. CI beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year CI has Outperformed its overall industry.

CI Sales Forecast

Next quarter’s sales forecast for CI is $62.44B with a range of $60.18B to $65.04B. The previous quarter’s sales results were $65.50B. CI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year CI has Outperformed its overall industry.
Next quarter’s sales forecast for CI is $62.44B with a range of $60.18B to $65.04B. The previous quarter’s sales results were $65.50B. CI beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.46% of the time in the same period. In the last calendar year CI has Outperformed its overall industry.

CI Stock Forecast FAQ

What is CI’s average 12-month price target, according to analysts?
Based on analyst ratings, Cigna Corp’s 12-month average price target is 380.79.
    What is CI’s upside potential, based on the analysts’ average price target?
    Cigna Corp has 20.89% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CI a Buy, Sell or Hold?
          Cigna Corp has a consensus rating of Strong Buy which is based on 16 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Cigna Corp’s price target?
            The average price target for Cigna Corp is 380.79. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $407.00 ,the lowest forecast is $341.00. The average price target represents 20.89% Increase from the current price of $314.99.
              What do analysts say about Cigna Corp?
              Cigna Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Streets Analysts.
                How can I buy shares of CI?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis